ストックスクリーナーアプリを入手
12.47
1.14%
0.14
Mbx Biosciences Inc (MBX) 最新ニュース
Strategic Growth and Clinical Advancements Propel MBX Biosciences to a Buy Rating - TipRanks
MBX Biosciences files IND application for MBX-4291 for obesity - BioWorld MedTech
MBX Biosciences announces IND application to FDA for MBX 4291 - TipRanks
MBX Biosciences Submits IND for Obesity Treatment - TipRanks
MBX Biosciences submits IND for once-monthly obesity treatment - Investing.com
MBX Biosciences Announces IND Submission Of MBX 4291, Its Long-Acting GLP1/GIP Receptor Co-Agonist Prodrug For The Treatment Of Obesity - MarketScreener
MBX Biosciences Announces IND Submission of MBX 4291, its - GlobeNewswire
MBX Biosciences Announces IND Submission of MBX 4291, its Long-acting GLP1/GIP Receptor ... - Eagle-Tribune
Bank of America Corp DE Makes New Investment in MBX Biosciences, Inc. (NYSE:MBX) - Defense World
Stifel reiterates buy rating on MBX Biosciences stock ahead of trial data - Investing.com Nigeria
Stifel reiterates buy rating on MBX Biosciences stock ahead of trial data By Investing.com - Investing.com South Africa
MBX Biosciences Announces Presentations on MBX 1416 at American Diabetes Association’s 85th Scientific Sessions - Nasdaq
MBX Biosciences to Present at the American Diabetes Association 85th Scientific Sessions - GlobeNewswire
MBX Biosciences Phase 1 Success: Revolutionary Weekly Treatment for Post-Bariatric Hypoglycemia Heads to Phase 2 - Stock Titan
MBX Biosciences Updates Corporate Presentation June 2025 - TipRanks
Nuveen Asset Management LLC Purchases Shares of 14,471 MBX Biosciences, Inc. (NYSE:MBX) - Defense World
BNP Paribas Financial Markets Makes New Investment in MBX Biosciences, Inc. (NYSE:MBX) - Defense World
mbx biosciences announces board changes and director elections - Investing.com Australia
mbx biosciences announces board changes and director elections By Investing.com - Investing.com South Africa
MBX Biosciences, Inc. Announces Departure of Carl L. Gordon from the Company's Board of Directors, Effective June 5, 2025 - marketscreener.com
MBX Biosciences Elects Directors at Annual Meeting - TipRanks
Deutsche Bank AG Buys New Position in MBX Biosciences, Inc. (NYSE:MBX) - Defense World
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Purchases Shares of 6,335 MBX Biosciences, Inc. (NYSE:MBX) - Defense World
MBX Biosciences: Consider Peptide Developer With GLP Drugs As A Speculative Buy - Seeking Alpha
MBX Biosciences, Inc. (NYSE:MBX) Given Consensus Rating of “Buy” by Brokerages - Defense World
MBX Biosciences, Inc. (NYSE:MBX) Shares Sold by Millennium Management LLC - Defense World
Northern Trust Corp Invests $1.67 Million in MBX Biosciences, Inc. (NYSE:MBX) - Defense World
MBX Biosciences to Participate in June Investor Conferences - GlobeNewswire
MBX Biosciences Showcases Precision Peptide Pipeline at Two Major Healthcare Conferences This June - Stock Titan
Citadel Advisors LLC Grows Stock Holdings in MBX Biosciences, Inc. (NYSE:MBX) - Defense World
MBX Biosciences, Inc. (NYSE:MBX) Shares Acquired by The Manufacturers Life Insurance Company - Defense World
MBX Biosciences Reports Q1 2025 Financial Progress - TipRanks
MBX Biosciences, Inc.: Strong Buy Rating Amid Promising Phase II Data and Robust Financial Position - TipRanks
Stifel maintains MBX Biosciences stock Buy rating, $40 target By Investing.com - Investing.com Nigeria
Stifel maintains MBX Biosciences stock Buy rating, $40 target - Investing.com
MBX Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
MBX Biosciences Reports First Quarter 2025 Financial Results and Recent Corporate Highlights - The Manila Times
Wells Fargo & Company MN Purchases Shares of 5,844 MBX Biosciences, Inc. (NYSE:MBX) - Defense World
Hypoglycemia Market Poised for Notable Growth by 2032, Fueled - openPR.com
MBX Biosciences Up 28%, Insider Buyers Are Up 19% - simplywall.st
MBX Biosciences, Inc. (NYSE:MBX) Receives Consensus Rating of “Buy” from Analysts - Defense World
MBX Biosciences, Inc. (NYSE:MBX) Shares Purchased by Geode Capital Management LLC - Defense World
JMP maintains MBX Biosciences stock $38 target, upbeat on trial data - Investing.com Australia
Companies Like MBX Biosciences (NASDAQ:MBX) Are In A Position To Invest In Growth - Yahoo Finance
MBX Biosciences to Participate in Citizens and RBC May Investor Conferences - The Manila Times
MBX Biosciences Reveals Growth Strategy at Citizens and RBC Healthcare Conferences: Key Updates Coming - Stock Titan
0.68%
0.50%
大文字化:
|
ボリューム (24 時間):